BIOMARKERS OF RESISTANCE TO HER2 INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140356349A1
SERIAL NO

13908382

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a method of suppressing resistance to an anticancer drug, comprising administering an inhibitor of expression or activity of ECM 1 (Extracellular Matrix Protein 1) to a cancer cell or an individual with cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION1 GWANAK-RO GWANAK-GU SEOUL 08826
INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY222 WANGSIMNI-RO SEONGDONG-GU SEOUL 04763

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
JU, Ji-Hyun Seoul, KR 2 2
LEE, Kyung-Min Seoul, KR 52 444
LEE, Tae-Hoon Gyeongbuk-do, KR 44 183
NOH, Dong-Young Seoul, KR 4 0
SHIN, In-Cheol Seoul, KR 9 71
YANG, Won-Seok Seoul, KR 4 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation